Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.

Paul TorenHervé BrissonDavid SimonyanHélène HovingtonLouis LacombeAlain BergeronYves Fradet

Published in: World journal of urology (2020)

The expression of AR and its relationship to clinical outcomes appears to vary between non-muscle invasive and muscle-invasive bladder cancer. Our results support the role of IC PD-L1 expression as an independent risk factor for bladder cancer outcomes.

Keyphrases

muscle invasive bladder cancer
free survival
poor prognosis
spinal cord injury
skeletal muscle
binding protein
long non coding rna
type diabetes
adipose tissue
urinary tract
insulin resistance